Bijan Nejadnik from SanBio, Inc, United State will be speaking on Efficacy and safety outcomes in patients with chronic traumatic brain injury: Final analysis of the randomized, double-blind, surgical sham-controlled phase 2 STEMTRA trial as Oral_Presenter at 3rd Edition of International Conference on Tissue Engineering and Regenerative Medicine organized by Magnus Group
Tissue Engineering Conferences 2023 | Regenerative Medicine Conference | Regenerative Medicine Congress | Regenerative Medicine Events | Regenerative Medicine Meetings | Regenerative Medicine Meetings 2023 | Tissue Engineering Events | Tissue Engineering Meetings | Tissue Engineering Events 2023 | Regenerative Medicine Conference | Regenerative Medicine Conferences 2023 | Tissue Engineering Congress 2023 | Regenerate Tissue Conferences 2023 | Tissue Engineering Conference | Tissue Engineering Conference 2023 | Regenerative Medicine Conferences | Regenerative Medicine Conferences
No comments:
Post a Comment